Advertisement

Drugs & Aging

, Volume 15, Issue 4, pp 297–306 | Cite as

Preventing Thromboembolic Complications in Older Orthopaedic Surgery Patients

Interventions and Outcomes
  • John W. Eikelboom
  • Jeffrey S. Ginsberg
Review Article

Abstract

The aging of the population in developed countries has been associated with a growing burden of degenerative joint disease and hip fracture, and this has contributed to a progressive increase in the utilisation of major hip and knee arthroplasty. In the absence of effective thromboprophylaxis, patients undergoing major orthopaedic surgery are at high risk of deep vein thrombosis, which may in turn lead to life-threatening complications such as pulmonary embolism, as well as long term sequelae including the post-thrombotic syndrome. However, increasing age is also associated with an increased risk of venous thromboembolism, and older orthopaedic patients are, therefore, at particularly high risk. Randomised trials have demonstrated that the risk of venous thromboembolism in these patients, as demonstrated by venography, can be reduced by more than 50% with the use of effective thromboprophylaxis. However, antithrombotic agents such as low molecular weight heparin and warfarin, which are widely used for the prevention of venous thromboembolism, are also associated with an increased risk of bleeding complications, and selection of the most appropriate strategy should, therefore, involve consideration of the potential risks as well as benefits of the currently available interventions.

Keywords

Adis International Limited Venous Thromboembolism Intermittent Pneumatic Compression Desirudin Venous Thromboem 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Silverstein MD, Heit JA, Mohr DN, et al. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med 1998 Mar 23; 158(6): 585–93PubMedCrossRefGoogle Scholar
  2. 2.
    Anderson Jr FA, Wheeler HB, Goldberg RJ, et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med 1991 May; 151(5): 933–8PubMedCrossRefGoogle Scholar
  3. 3.
    Dalen JE, Alpert JS. Natural history of pulmonary embolism. Prog Cardiovasc Dis 1975 Jan–Feb; 17(4): 257–70CrossRefGoogle Scholar
  4. 4.
    Sandier DA, Martin JF. Autopsy proven pulmonary embolism in hospital patients: are we detecting enough deep vein thrombosis? J R Soc Med 1989 Apr; 82(4): 203–5Google Scholar
  5. 5.
    Prandoni P, Lensing AW, Cogo A, et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med 1996 Jul 1; 125(1): 1–7PubMedGoogle Scholar
  6. 6.
    Brandjes DP, Buller HR, Heijboer H, et al. Randomised trial of effect of compression stockings in patients with symptomatic proximal-vein thrombosis. Lancet 1997 Mar 15; 349(9054): 759–62PubMedCrossRefGoogle Scholar
  7. 7.
    Clagett GP, Anderson Jr FA, Geerts W, et al. Prevention of venous thromboembolism. Chest 1998 Nov; 114(5 Suppl.): 531S–60PubMedCrossRefGoogle Scholar
  8. 8.
    Leclerc JR, Gent M, Hirsh J, et al. The incidence of symptomatic venous thromboembolism during and after prophylaxis with enoxaparin: a multi-institutional cohort study of patients who underwent hip or knee arthroplasty: Canadian Collaborative Group. Arch Intern Med 1998 Apr 27; 158(8): 873–8PubMedCrossRefGoogle Scholar
  9. 9.
    Robinson KS, Anderson DR, Gross M, et al. Ultrasonographic screening before hospital discharge for deep venous thrombosis after arthroplasty: the post-arthroplasty screening study: a randomized, controlled trial. Ann Intern Med 1997 Sep 15; 127(6): 439–45PubMedGoogle Scholar
  10. 10.
    Madhok R, Lewallen DG, Wallrichs SL, et al. Trends in the utilization of primary total hip arthroplasty, 1969 through 1990: a population-based study in Olmsted County, Minnesota. Mayo Clin Proc 1993 Jan; 68(1): 11–8PubMedGoogle Scholar
  11. 11.
    Quam JP, Michet Jr CJ, Wilson MG, et al. Total knee arthroplasty: a population-based study. Mayo Clin Proc 1991 Jun; 66(6): 589–95PubMedGoogle Scholar
  12. 12.
    Seagroatt V, Tan HS, Goldacre M, et al. Elective total hip replacement: incidence, emergency readmission rate, and postoperative mortality. BMJ 1991 Dec 7; 303(6815): 1431–5PubMedCrossRefGoogle Scholar
  13. 13.
    Rajaratnam G, Black NA, Dalziel M. Total hip replacements in the National Health Service: is need being met? J Pub Health Med 1990 Feb; 12(1): 56–9Google Scholar
  14. 14.
    Siddique RM, Siddique MI, Connors Jr AF, et al. Thirty-day case-fatality rates for pulmonary embolism in the elderly. Arch Intern Med 1996 Nov 11; 156(20): 2343–7PubMedCrossRefGoogle Scholar
  15. 15.
    Mari D, Mannucci PM, Coppola R, et al. Hypercoagulability in centenarians: the paradox of successful aging. Blood 1995 Jun 1; 85(11): 3144–9PubMedGoogle Scholar
  16. 16.
    Tracy RP, Bovill EG, Fried LP, et al. The distribution of coagulation factors VII and VIII and fibrinogen in adults over 65 years: results from the Cardiovascular Health Study. Ann Epidemiol 1992 Jul; 2(4): 509–19PubMedCrossRefGoogle Scholar
  17. 17.
    Nurmohamed MT, Buller HR, ten Cate JW. Physiological changes due to age: implications for the prevention and treatment of thrombosis in older patients. Drugs Aging 1994 Jul; 5(1): 20–33PubMedCrossRefGoogle Scholar
  18. 18.
    Schina Jr MJ, Neumyer MM, Healy DA, et al. Influence of age on venous physiologic parameters. J Vasc Surg 1993 Nov; 18(5): 749–52PubMedCrossRefGoogle Scholar
  19. 19.
    Weinmann EE, Salzman EW. Deep-vein thrombosis. N Engl J Med 1994 Dec 15; 331(24): 1630–41PubMedCrossRefGoogle Scholar
  20. 20.
    Lohr JM, James KV, Deshmukh RM, et al. Allastair B. Karmody Award: calf vein thrombi are not a benign finding. Am J Surg 1995 Aug; 170(2): 86–90PubMedCrossRefGoogle Scholar
  21. 21.
    Lagerstedt CI, Olsson CG, Fagher BO, et al. Need for long-term anticoagulant treatment in symptomatic calf-vein thrombosis. Lancet 1985 Sep 7; II(8454): 515–8CrossRefGoogle Scholar
  22. 22.
    Moser KM, LeMoine JR. Is embolic risk conditioned by location of deep venous thrombosis? Ann Intern Med 1981 Apr; 94 (4 Pt 1): 439–44PubMedGoogle Scholar
  23. 23.
    Parmet JL, Berman AT, Horrow JC, et al. Thromboembolism coincident with tourniquet deflation during total knee arthroplasty. Lancet 1993 Apr 24; 341(8852): 1057–8PubMedCrossRefGoogle Scholar
  24. 24.
    Planes A, Vochelle N, Darmon JY, et al. Risk of deep-venous thrombosis after hospital discharge in patients having undergone total hip replacement: double-blind randomised comparison of enoxaparin versus placebo. Lancet 1996 Jul 27; 348(9022): 224–8PubMedCrossRefGoogle Scholar
  25. 25.
    Bergqvist D, Benoni G, Bjorgell O, et al. Low-molecular-weight heparin (enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement. N Engl J Med 1996 Sep 5; 335(10): 696–700PubMedCrossRefGoogle Scholar
  26. 26.
    Dahl OE, Andreassen G, Aspelin T, et al. Prolonged thromboprophylaxis following hip replacement surgery: results of a double-blind, prospective, randomised, placebo-controlled study with dalteparin. Thromb Haemost 1997 Jan; 77(1): 26–31PubMedGoogle Scholar
  27. 27.
    Schneider EL, Guralnik JM. The aging of America: impact on health care costs. JAMA 1990 May 2; 263(17): 2335–40PubMedCrossRefGoogle Scholar
  28. 28.
    Prins MH, Hirsh J. A comparison of general and regional anesthesia as a risk factor for deep vein thrombosis following hip surgery: a critical review. Thromb Haemost 1990 Dec 28; 64(4): 497–500PubMedGoogle Scholar
  29. 29.
    Nicolaides AN, Bergqvist D, Hull R, et al. Prevention of venous thromboembolism: international consensus statement (guidelines according to scientific evidence). Int Angiol 1997 Mar; 16(1): 3–38Google Scholar
  30. 30.
    Guyatt GH, Cook DJ, Sackett DL, et al. Grades of recommendation for antithrombotic agents. Chest 1998 Nov; 114(5 Suppl.): 441S–4PubMedCrossRefGoogle Scholar
  31. 31.
    Perez JV, Warwick DJ, Case CP, et al. Death after proximal femoral fracture: an autopsy study. Injury 1995 May; 26(4): 237–40PubMedCrossRefGoogle Scholar
  32. 32.
    Todd CJ, Freeman CJ, Camilleri-Ferrante C, et al. Differences in mortality after fracture of hip: the east Anglian audit. BMJ 1995 Apr 8; 310(6984): 904–8PubMedCrossRefGoogle Scholar
  33. 33.
    Wells PS, Lensing AW, Hirsh J. Graduated compression stockings in the prevention of postoperative venous thromboembolism: a meta-analysis. Arch Intern Med 1994 Jan 10; 154(1): 67–72PubMedCrossRefGoogle Scholar
  34. 34.
    Westrich GH, Sculce TP. Prophylaxis against deep vein thrombosis after total knee arthroplasty: pneumatic plantar compression and aspirin compared with aspirin alone. J Bone Joint Surg Am 1996 Jun; 78(6): 826–34PubMedGoogle Scholar
  35. 35.
    Antiplatelet Trialists’ Collaboration. Collaborative overview of randomised trials of antiplatelet therapy: III. Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients. BMJ 1994 Jan 22; 308(6923): 235–46CrossRefGoogle Scholar
  36. 36.
    Collins R, Baigent C, Sandercock P, et al. Antiplatelet therapy for thromboprophylaxis: the need for careful consideration of the evidence from randomised trials. BMJ 1994 Nov 5; 309(6963): 1215–7PubMedCrossRefGoogle Scholar
  37. 37.
    Lotke PA, Palevsky H, Keenan AM, et al. Aspirin and warfarin for thromboembolic disease after total joint arthroplasty. Clin Orthop 1996 Mar; (324): 251–8Google Scholar
  38. 38.
    Graor RA, Stewart JH, Lotke PA, et al. RD heparin (ardeparin sodium) vs aspirin to prevent deep vein thrombosis after hip or knee replacement surgery [abstract]. Chest 1992 Aug; 102(2 Suppl.): 118SGoogle Scholar
  39. 39.
    Leyvraz PF, Richard J, Bachmann F, et al. Adjusted versus fixed dose subcutaneous heparin in the prevention of deep vein thrombosis after total hip replacement. N Engl J Med 1983 Oct 20; 309(16): 954–8PubMedCrossRefGoogle Scholar
  40. 40.
    The German Hip Arthroplasty Trial (GHAT) Group. Prevention of deep vein thrombosis with low molecular-weight heparin in patients undergoing total hip replacement: a randomized trial. Arch Orthop Trauma Surg 1992; 111(2): 110–20CrossRefGoogle Scholar
  41. 41.
    Dechavanne M, Ville D, Berruyer M, et al. Randomized trial of a low-molecular-weight heparin (kabi 2165) versus adjusted-dose subcutaneous standard heparin in the prophylaxis of deep-vein thrombosis after elective hip surgery. Haemostasis 1989; 19(1): 5–12PubMedGoogle Scholar
  42. 42.
    Hull RD, Raskob GE, Pineo GF, et al. A comparison of subcutaneous low-molecular-weight heparin with warfarin sodium for prophylaxis against deep-vein thrombosis after hip or knee implantation. N Engl J Med 1993 Nov 4; 329(19): 1370–6PubMedCrossRefGoogle Scholar
  43. 43.
    RD Heparin Arthroplasty Group. RD heparin compared with warfarin for prevention of venous thromboembolic disease following total hip or knee arthroplasty. J Bone Joint Surg Am 1994 Aug; 76(8): 1174–85Google Scholar
  44. 44.
    Francis CW, Pellegrini Jr VD, Totterman S, et al. Prevention of deep-vein thrombosis after total hip arthroplasty: comparison of warfarin and dalteparin. J Bone Joint Surg Am 1997 Sep; 79(9): 1365–72PubMedGoogle Scholar
  45. 45.
    Mohr DN, Silverstein MD, Murtaugh PA, et al. Prophylactic agents for deep vein thrombosis in elective hip surgery. Arch Intern Med 1993 Oct 11; 153(19): 2221–8PubMedCrossRefGoogle Scholar
  46. 46.
    Imperiale TF, Speroff T. A meta-analysis of methods to prevent venous thromboembolism following total hip replacement. JAMA 1994 Jun 8; 271(22): 1780–5PubMedCrossRefGoogle Scholar
  47. 47.
    Heit JA, Berkowitz SD, Bona R, et al. Efficacy and safety of low molecular weight heparin (ardeparin sodium) compared to warfarin for the prevention of venous thromboembolism after total knee replacement surgery: a double-blind, dose-ranging study: Ardeparin Arthroplasty Study Group. Thromb Haemost 1997 Jan; 77(1): 32–8PubMedGoogle Scholar
  48. 48.
    Spiro TE, Fitzgerald RH, Trowbridge AA, et al. Efficacy and safety of enoxaparin to prevent deep venous thrombosis after hip replacement surgery: enoxaparin Clinical Trial Group. Ann Intern Med 1994 Jul 15; 121(2): 81–9PubMedGoogle Scholar
  49. 49.
    Leclerc JR, Geerts WH, Desjardins L, et al. Prevention of venous thromboembolism after knee arthroplasty: a randomized, double-blind trial comparing enoxaparin with warfarin. Ann Intern Med 1996 Apr 1; 124(7): 619–26PubMedGoogle Scholar
  50. 50.
    Eriksson BI, Ekman S, Kalebo P, et al. Prevention of deep-vein thrombosis after total hip replacement: direct thrombin inhibition with recombinant hirudin, CGP 39393. Lancet 1996 Mar 9; 347(9002): 635–9PubMedCrossRefGoogle Scholar
  51. 51.
    Eriksson BI, Ekman S, Lindbratt S, et al. Prevention of thromboembolism with use of recombinant hirudin: results of a double-blind, multicenter trial comparing the efficacy of desirudin (revasc) with that of unfractionated heparin in patients having a total hip replacement. J Bone Joint Surg Am 1997 Mar; 79(3): 326–33PubMedGoogle Scholar
  52. 52.
    Eriksson BI, Wille-Jorgensen P, Kalebo P, et al. A comparison of recombinant hirudin with a low-molecular-weight heparin to prevent thromboembolic complications after total hip replacement. N Engl J Med 1997 Nov 6; 337(19): 1329–35PubMedCrossRefGoogle Scholar
  53. 53.
    Ginsberg JS, Nurmohamed MT, Gent M, et al. Use of hirulog in the prevention of venous thrombosis after major hip or knee surgery. Circulation 1994 Nov; 90(5): 2385–9PubMedCrossRefGoogle Scholar
  54. 54.
    Hull RD, Brant RF, Pineo GF, et al. Preoperative vs postoperative initiation of low-molecular-weight heparin prophylaxis against venous thromboembolism in patients undergoing elective hip replacement. Arch Intern Med 1999; 159: 137–41PubMedCrossRefGoogle Scholar
  55. 55.
    Horlocker TT, Heit JA. Low molecular weight heparin: biochemistry, pharmacology, perioperative prophylaxis regimens, and guidelines for regional anesthetic management. Anesth Analg 1997 Oct; 85(4): 874–85PubMedGoogle Scholar
  56. 56.
    Hirsh J. Evidence for the needs of out-of-hospital thrombosis prophylaxis: introduction. Chest 1998 Aug; 114(2 Suppl.): 113S–14PubMedCrossRefGoogle Scholar

Copyright information

© Adis International Limited 1999

Authors and Affiliations

  1. 1.Preventive Cardiology and Therapeutics ProgramMcMaster UniversityHamiltonCanada
  2. 2.Department of MedicineMcMaster UniversityHamiltonCanada

Personalised recommendations